Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-008892
Filing Date
2019-07-30
Accepted
2019-07-30 16:03:21
Documents
2
Period of Report
2019-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1797
2 EX-24 POWER OF ATTORNEY ex24colehughm.txt EX-24 5008
  Complete submission text file 0001179110-19-008892.txt   8223
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARIAD PHARMACEUTICALS, INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cole Hugh M (Reporting) CIK: 0001604646 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 19985489